Skip to main content
Erschienen in: Obesity Surgery 11/2019

13.07.2019 | Review

A Systematic Review and Meta-Analysis of the Effect of Roux-en-Y Gastric Bypass on Barrett’s Esophagus

verfasst von: Md Tanveer Adil, Omer Al-taan, Farhan Rashid, Aruna Munasinghe, Vigyan Jain, Douglas Whitelaw, Periyathambi Jambulingam, Kamal Mahawar

Erschienen in: Obesity Surgery | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity is associated with a twofold risk of gastroesophageal reflux disease (GERD) and thrice the risk of Barrett’s esophagus (BE). Roux-en-Y gastric bypass (RYGB) leads to weight loss and improvement of GERD in population with obesity, but its effect on BE is less clear.

Methods

Bibliographic databases were searched systematically for relevant articles till January 31, 2019. Studies evaluating the effect of RYGB on BE with preoperative and postoperative endoscopy and biopsy were included. Study quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS) tool. Meta-analysis was conducted using Mantel-Haenszel, random effects model and presented as risk difference (RD) or odds ratio (OR) with 95% confidence intervals.

Results

Eight studies with 10,779 patients undergoing RYGB reported on 117 patients with BE with follow-up of > 1 year. Significant regression of BE after RYGB was observed (RD − 0.56.95% c.i. − 0.69 to − 0.43; P < 0.001). Subgroup analysis showed regression of both short-segment BE [ssBE] (RD − 0.51.95% c.i. − 0.68 to − 0.33; P < 0.001) and long-segment BE [lsBE] (RD − 0.46.95% c.i. − 0.71 to − 0.21; P < 0.001). RYGB also caused improvement in GERD in patients of BE (RD − 0.93, 95% c.i. − 1.04 to − 0.81; P < 0.001). RYGB was strongly associated with regression of BE compared with progression (OR 31.2.95% c.i. 11.37 to 85.63; P < 0.001).

Conclusions

RYGB leads to significant improvement of BE at > 1 year after surgery in terms of regression and resolution of the associated GERD. Both ssBE and lsBE improve after RYGB significantly.
Literatur
1.
Zurück zum Zitat Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.PubMedCrossRef Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.PubMedCrossRef
2.
Zurück zum Zitat Moersch RN, Ellis Jr FH, Mc DJ. Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet. 1959;108:476–84.PubMed Moersch RN, Ellis Jr FH, Mc DJ. Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet. 1959;108:476–84.PubMed
3.
Zurück zum Zitat Stein HJ, Siewart JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8(3):276–88.PubMedCrossRef Stein HJ, Siewart JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8(3):276–88.PubMedCrossRef
4.
Zurück zum Zitat Hamade N, Vennelaganti S, Parasa S, et al. Lower annual rate of progression of short-segment vs long-segment Barrett’s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2019;17(5):864-868.PubMedCrossRef Hamade N, Vennelaganti S, Parasa S, et al. Lower annual rate of progression of short-segment vs long-segment Barrett’s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2019;17(5):864-868.PubMedCrossRef
5.
Zurück zum Zitat Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am. 2015;44(2):203–31.CrossRef Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am. 2015;44(2):203–31.CrossRef
6.
Zurück zum Zitat Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett’s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61(2):226–31.PubMedCrossRef Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett’s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61(2):226–31.PubMedCrossRef
7.
Zurück zum Zitat Braghetto I, Csendes A. Patients having bariatric surgery: surgical options in morbidly obese patients with Barrett’s esophagus. Obes Surg. 2016;26:1622–6.PubMedCrossRef Braghetto I, Csendes A. Patients having bariatric surgery: surgical options in morbidly obese patients with Barrett’s esophagus. Obes Surg. 2016;26:1622–6.PubMedCrossRef
8.
Zurück zum Zitat Nandurkar S, Locke 3rd GR, Fett S, et al. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004;20(5):497–505.PubMedCrossRef Nandurkar S, Locke 3rd GR, Fett S, et al. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004;20(5):497–505.PubMedCrossRef
9.
Zurück zum Zitat Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:872–8.CrossRef Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:872–8.CrossRef
10.
Zurück zum Zitat Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.PubMedCrossRef Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.PubMedCrossRef
11.
Zurück zum Zitat Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 1998;93:1028–32.PubMedCrossRef Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 1998;93:1028–32.PubMedCrossRef
12.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.PubMedPubMedCentralCrossRef Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Zhang N, Maffei A, Cerabona T, et al. Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc. 2013;27(4):1273–80.PubMedCrossRef Zhang N, Maffei A, Cerabona T, et al. Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc. 2013;27(4):1273–80.PubMedCrossRef
14.
Zurück zum Zitat Park C, Portenier D. Reflux, Barrett’s esophagus & bariatric surgery: working towards a clinical pathway for the management of a pre-cancerous condition in bariatric surgery patients. Surg Obes Relat Dis. 2015;11(6):S118.CrossRef Park C, Portenier D. Reflux, Barrett’s esophagus & bariatric surgery: working towards a clinical pathway for the management of a pre-cancerous condition in bariatric surgery patients. Surg Obes Relat Dis. 2015;11(6):S118.CrossRef
15.
Zurück zum Zitat Cobey F, Oelschlager B. Complete regression of Barrett’s esophagus after Roux-en-Y gastric bypass. Obes Surg. 2005;15:710–2.PubMedCrossRef Cobey F, Oelschlager B. Complete regression of Barrett’s esophagus after Roux-en-Y gastric bypass. Obes Surg. 2005;15:710–2.PubMedCrossRef
18.
Zurück zum Zitat Moher D, Liberali A, Telzlaff J, et al. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. BMJ. 2009;339:b2535.PubMedPubMedCentralCrossRef Moher D, Liberali A, Telzlaff J, et al. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. BMJ. 2009;339:b2535.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef
20.
Zurück zum Zitat Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.PubMedCrossRef Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.PubMedCrossRef
22.
24.
Zurück zum Zitat Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.PubMedCrossRef Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.PubMedCrossRef
25.
Zurück zum Zitat Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4(1):1–4.PubMedCrossRef Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4(1):1–4.PubMedCrossRef
26.
Zurück zum Zitat Ben-Meir A, Sonpal I, Salomone MG. Roux-en-Y gastric bypass (RYGB) improves Barrett’s esophagus. Surg Obes Relat Dis. 2010;6(3):S48–9.CrossRef Ben-Meir A, Sonpal I, Salomone MG. Roux-en-Y gastric bypass (RYGB) improves Barrett’s esophagus. Surg Obes Relat Dis. 2010;6(3):S48–9.CrossRef
27.
Zurück zum Zitat Braghetto I, Korn O, Csendes A, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22(5):764–72.PubMedCrossRef Braghetto I, Korn O, Csendes A, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22(5):764–72.PubMedCrossRef
28.
Zurück zum Zitat Pereira N, Csendes A, Smok G, et al. Effects of gastric bypass for morbid obesity on Barrett esophagus. Rev Chilena Cirugía. 2012;64(2):155–60.CrossRef Pereira N, Csendes A, Smok G, et al. Effects of gastric bypass for morbid obesity on Barrett esophagus. Rev Chilena Cirugía. 2012;64(2):155–60.CrossRef
29.
Zurück zum Zitat Dova G, Caro LE, Brasesco O, et al. Effects of gastric bypass in obese patients with Barrett’s esophagus. Gastrointest Endosc. 2016;83(5):AB551.CrossRef Dova G, Caro LE, Brasesco O, et al. Effects of gastric bypass in obese patients with Barrett’s esophagus. Gastrointest Endosc. 2016;83(5):AB551.CrossRef
30.
Zurück zum Zitat Gorodner V, Buxhoeveden R, Clemente G, et al. Barrett’s esophagus after roux-en-Y gastric bypass: does regression occur? Surg Endosc. 2017;31(4):1849–54.PubMedCrossRef Gorodner V, Buxhoeveden R, Clemente G, et al. Barrett’s esophagus after roux-en-Y gastric bypass: does regression occur? Surg Endosc. 2017;31(4):1849–54.PubMedCrossRef
31.
Zurück zum Zitat Andrew B, Alley JB, Aquiar CE, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32(2):930–6.PubMedCrossRef Andrew B, Alley JB, Aquiar CE, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32(2):930–6.PubMedCrossRef
32.
Zurück zum Zitat Nguyen DM, El-Serag HB, Henderson L, et al. Medication usage and the risk of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2009;7:1299–304.PubMedPubMedCentralCrossRef Nguyen DM, El-Serag HB, Henderson L, et al. Medication usage and the risk of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2009;7:1299–304.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.PubMedCrossRef Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.PubMedCrossRef
34.
Zurück zum Zitat Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2011;106:1899–908.PubMedPubMedCentralCrossRef Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2011;106:1899–908.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Mino-Kenudson M, Brugge WR, Puricelli WP, et al. Management of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol. 2005;29:680–6.PubMedCrossRef Mino-Kenudson M, Brugge WR, Puricelli WP, et al. Management of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol. 2005;29:680–6.PubMedCrossRef
36.
Zurück zum Zitat Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut. 2010;59:1169–77.PubMedCrossRef Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut. 2010;59:1169–77.PubMedCrossRef
37.
Zurück zum Zitat Simonka Z, Paszt A, Abraham S, et al. The effects of laparoscopic Nissen fundoplication on Barrett’s esophagus: long-term results. Scand J Gastroenterol. 2012;47:13–21.PubMedCrossRef Simonka Z, Paszt A, Abraham S, et al. The effects of laparoscopic Nissen fundoplication on Barrett’s esophagus: long-term results. Scand J Gastroenterol. 2012;47:13–21.PubMedCrossRef
38.
Zurück zum Zitat Hofstetter WL, Peters JH, DeMeester TR, et al. Long-term outcome of antireflux surgery in patients with Barrett’s esophagus. Ann Surg. 2001;234:532–8.PubMedPubMedCentralCrossRef Hofstetter WL, Peters JH, DeMeester TR, et al. Long-term outcome of antireflux surgery in patients with Barrett’s esophagus. Ann Surg. 2001;234:532–8.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Guruski RR, Peters JH, Hagen JA, et al. Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg. 2003;196(5):706–12.CrossRef Guruski RR, Peters JH, Hagen JA, et al. Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg. 2003;196(5):706–12.CrossRef
40.
Zurück zum Zitat Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.PubMedPubMedCentral Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.PubMedPubMedCentral
41.
Zurück zum Zitat Zehetner J, DeMeester SR, Ayazi S, et al. Long-term follow-up after anti-reflux surgery in patients with Barrett’s esophagus. J Gastrointest Surg. 2010;14:1483–91.PubMedCrossRef Zehetner J, DeMeester SR, Ayazi S, et al. Long-term follow-up after anti-reflux surgery in patients with Barrett’s esophagus. J Gastrointest Surg. 2010;14:1483–91.PubMedCrossRef
42.
Zurück zum Zitat Kellogg TA, Andrade R, Maddaus M, et al. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):52–7.PubMedCrossRef Kellogg TA, Andrade R, Maddaus M, et al. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):52–7.PubMedCrossRef
43.
Zurück zum Zitat Morgenthal CB, Lin E, Shane MD, et al. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc. 2007;21(11):1978–84.PubMedCrossRef Morgenthal CB, Lin E, Shane MD, et al. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc. 2007;21(11):1978–84.PubMedCrossRef
44.
Zurück zum Zitat Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc. 2001;15:986–9.PubMedCrossRef Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc. 2001;15:986–9.PubMedCrossRef
45.
Zurück zum Zitat Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19:200–21.PubMedCrossRef Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19:200–21.PubMedCrossRef
46.
Zurück zum Zitat Anderson MA, Gan SI, Fanelli RD, et al. Role of endoscopy in the bariatric surgery patient. Gastrointest Endosc. 2008;68:1–10.PubMedCrossRef Anderson MA, Gan SI, Fanelli RD, et al. Role of endoscopy in the bariatric surgery patient. Gastrointest Endosc. 2008;68:1–10.PubMedCrossRef
47.
Zurück zum Zitat Abd EME, Alfalah H, Asker WA, et al. Place of upper endoscopy before and after bariatric surgery: a multicenter experience with 3219 patients. World J Gastrointest Endosc. 2016;8(10):409–17.CrossRef Abd EME, Alfalah H, Asker WA, et al. Place of upper endoscopy before and after bariatric surgery: a multicenter experience with 3219 patients. World J Gastrointest Endosc. 2016;8(10):409–17.CrossRef
48.
Zurück zum Zitat Gomez V, Bhalla R, Heckman MG, et al. Routine screening endoscopy before bariatric surgery: is it necessary? Bariatr Surg Pract Patient Care. 2014;9(4):143–9.PubMedPubMedCentralCrossRef Gomez V, Bhalla R, Heckman MG, et al. Routine screening endoscopy before bariatric surgery: is it necessary? Bariatr Surg Pract Patient Care. 2014;9(4):143–9.PubMedPubMedCentralCrossRef
Metadaten
Titel
A Systematic Review and Meta-Analysis of the Effect of Roux-en-Y Gastric Bypass on Barrett’s Esophagus
verfasst von
Md Tanveer Adil
Omer Al-taan
Farhan Rashid
Aruna Munasinghe
Vigyan Jain
Douglas Whitelaw
Periyathambi Jambulingam
Kamal Mahawar
Publikationsdatum
13.07.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04083-0

Weitere Artikel der Ausgabe 11/2019

Obesity Surgery 11/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.